A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer (Q43445011)
Jump to navigation
Jump to search
scientific article published on 14 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer |
scientific article published on 14 December 2010 |
Statements
1 reference
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer (English)
1 reference
Faith Nathan
1 reference
Kristine Pemberton
1 reference
Thomas Morris
1 reference
14 December 2010
1 reference
1 reference
67
1 reference
5
1 reference
1203-1208
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference